Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2011
Metabolism and pharmacokinetics of morinidazole in humans: identification of diastereoisomeric morpholine N+-glucuronides catalyzed by UDP glucuronosyltransferase 1A9Ruina Gao, Liang Li, Cen Xie, et al.Organic & Biomolecular Chemistry|July 26, 2012
A NIR BODIPY dye bearing 3,4,4a-trihydroxanthene moietiesXin-Dong Jiang, Ruina Gao, Yi Yue, et al.Antimicrobial Agents and Chemotherapy|July 30, 2014
Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjectsXiaoyan Pang, Yifan Zhang, Ruina Gao, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 6, 2012
Simultaneous determination of morinidazole, its N-oxide, sulfate, and diastereoisomeric N(+)-glucuronides in human plasma by liquid chromatography-tandem mass spectrometryRuina Gao, Dafang Zhong, Ke Liu, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 2, 2018
Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usageTingting Fu, Ruina Gao, Paul Scott-Stevens, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 18, 2017
Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance ProteinHoufu Liu, Liang Huang, Yi Li, et al.Bioorganic & Medicinal Chemistry|January 7, 2014
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitorsYonghui Wang, Wei Cai, Guifeng Zhang, et al.Pageof 1